Skip to content

Medifast MED Investment Proceeds

Investment Proceeds at other companies

Travel + Leisure logo
Travel + LeisureTNL
$9M
Vontier logo
VontierVNT
$1M
Archer Aviation logo
Archer AviationACHR
$115M
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$145.66M+231%
GitLab logo
GitLabGTLB
$9.92M+626%
CNB Financial logo
CNB FinancialCCNE
$36.67M

Other financials

Income statement

See full
Revenue$76.0M-34.3%
Gross profit$51.8M-38.6%
Operating income-$3.3M-161%
Net income-$2.1M-175%
EPS (diluted)-$0.19-171%

Balance sheet

See full
Cash & equivalents$71.5M-22.0%
Total debt$16.1M+10.2%
Total equity$197.7M-6.3%
Total assets$252.0M-10.0%

Cash flow

See full
Operating cash flow$260.0K-92.4%
CapEx$1.1M-28.0%
Free cash flow-$836.0K-144%

Valuation

See full
Market cap$121.87M-17.4%
Enterprise value$66.44M+12.8%
P/S0.4×0.0×

Profitability

See full
Gross margin70.1%-3.8pp
Operating margin-4.7%-7.0pp
Net margin-5.8%-8.1pp
FCF margin5%-9.3pp

Returns & leverage

See full
Return on equity-9.8%-20.1pp
Debt / equity0.1×0.0×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medifast's investment proceeds?
Medifast (MED) reported investment proceeds of $29.65M in Q1 2026.
How has Medifast's investment proceeds changed year-over-year?
Medifast's investment proceeds increased by 105.0% year-over-year, from $14.46M to $29.65M.
What is the long-term trend for Medifast's investment proceeds?
Over 2 years (2023 to 2025), Medifast's investment proceeds has grown at a 297.6% compound annual growth rate (CAGR), from $5.19M to $82.09M.
What does investment proceeds mean?
Cash received from sales, maturities, and redemptions of investment securities across all categories.